查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物製品合同開發市場規模、份額和趨勢分析報告：按來源、按服務類型、按適應症、按地區、細分市場趨勢：2023-2030
市場調查報告書
商品編碼
1301078

生物製品合同開發市場規模、份額和趨勢分析報告：按來源、按服務類型、按適應症、按地區、細分市場趨勢：2023-2030

Biologics Contract Development Market Size, Share & Trends Analysis Report By Source (Mammalian, Microbial), By Service Type, By Indication (Oncology, Immunological Disorders), By Region And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

生物製劑合同開發市場的增長和趨勢

根據 GrandView Research, Inc. 最新報告，2023 年至 2030 年全球合同生物製劑開發市場規模將以 8.1% 的複合年增長率增長，預計 2030 年達到 138 億美元那

市場驅動因素包括提供細胞系、上游和下游工藝、分析方法和製劑開發等服務的組織。 這些組織專門開發和製造穩定細胞系，這些細胞系廣泛用於多種重要應用，包括藥物篩選、基因功能研究和生物製劑製造。

生物製藥公司和 CDO 之間的併購和聯合研究的增加也是推動市場增長的因素之一，從而實現了金融穩定性和先進專業技術的融合。 例如，2022 年 9 月，Lonza 與生物技術公司 Touchlight 合作，利用不同來源的 DNA 來開發 mRNA，擴大其產品組合。 Touchlight 已與 Lonza 合作獲得 Lonza 的新技術 Dog Bone DNA (dbDNA)。

許多生物製藥和製藥公司通過外包來加快工作流程（速度）、提供獨特的專業服務、降低藥物開發成本並提供專業知識。因此，越來越多的人正在考慮外包。 這些因素預計將促進合同生物製劑開發行業的增長。

在 COVID-19 大流行期間，大多數臨床試驗的重點是開發治療 COVID-19 的新療法。 然而，在大流行後時期，由於癌症患病率不斷上升，預計調查將集中在癌症上。 單克隆抗體等生物製劑在癌症治療中廣受歡迎。 生物製劑在癌症治療中的巨大潛力和癌症研究的增加可能會支持未來幾年的市場增長。

生物製劑合同開發市場報告亮點

  • 到 2022 年，哺乳動物產品將成為最大的產品類別，份額超過 52.0%。
  • 由於許多公司選擇外包重組蛋白和單克隆抗體 (MAB) 的生產，預計工藝開發將在預測期內實現最高的複合年增長率。
  • 北美在 2019 年主導全球市場。 戰略收購和合作夥伴關係的增加以及對專業測試服務的需求的增加預計將產生積極影響
  • 預計亞太地區在預測期內的複合年增長率最高。 除此之外，監管機構還進行了各種修訂，以改變臨床試驗評估標準，以滿足全球要求並增加對亞太地區的投資。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 調查方法
  • 信息獲取
  • 信息或數據分析
  • 市場形成和驗證
  • 按地區計算市場
  • 型號詳細信息
  • 主要信息列表
  • 縮寫列表
  • 輔助信息列表
  • 目的

第 2 章執行摘要

  • 市場前景

第 3 章合同生物製劑開發市場：變量、趨勢和範圍

  • 市場細分和範圍
  • 市場動態
    • 市場驅動因素分析
    • 更多地採用先進技術
    • 加強合併與合作
    • 新興國家臨床試驗的良好環境
    • 研發活動外包增加
    • 市場製約因素分析
    • 知識產權問題
  • 採用和增長前景圖
  • 生物製劑的合同開發：市場分析工具
    • 行業分析 - 波特五力
    • PESTEL 分析
  • COVID-19 對生物製劑合同開發市場的影響

第 4 章生物製劑合同開發市場：來源類型細分分析

  • 合同生物製劑開發市場：2022 年和 2030 年市場份額分析
    • 微生物
    • 哺乳動物
    • 其他

第五章生物製劑合同開發市場：服務細分

  • 合同生物製劑開發市場：2022 年和 2030 年市場份額分析
  • 細胞系開發
    • 細胞系開發市場，2018-2030
    • 工藝開發
    • 下游工藝開發
    • 下游工藝，副產品
  • 其他服務（例如質量和監管服務）
    • 其他市場，2018-2030 年

第六章生物製劑合同開發市場：適應症細分市場分析

  • 合同生物製劑開發市場：2022 年和 2030 年市場份額分析
  • 腫瘤學
  • 免疫性疾病
  • 心血管疾病
  • 血液病
  • 其他

第 7 章。合同生物製品開發市場：區域分析

  • 生物製品的合同開發：2022 年和 2030 年區域市場份額分析
  • 北美
    • 北美合同生物製劑開發市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲生物製品合同開發市場
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
  • 亞太地區
    • 2018-2030 年亞太地區生物製品合同開發市場
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
  • 拉丁美洲
    • 拉丁美洲合約生物製劑開發市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
  • MEA
    • MEA 合同生物製劑開發市場，2018-2030 年
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第八章公司簡介

  • 競爭格局
  • 公司簡介
    • Wuxi Biologics
    • Abzena Ltd
    • Fujifilm Diosynth Biotechnologies
    • Kbi Biopharma
    • Agc Biologics
    • Thermo Fischer Scientific Inc.
    • Curia Global, Inc
    • Genscript
    • Bionova Scientific Inc.
    • Bioxcellence（Boehringer Ingelheim Biopharmaceuticals Gmbh）
    • Stc Biologics
Product Code: GVR-4-68038-983-8

Biologics Contract Development Market Growth & Trends

The global biologics contract development market size is expected to reach USD 13.8 billion by 2030, expanding at 8.1% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Key drivers attributed to the growth include rising adoption of advanced technologies by biologics manufacturers, M&A, and clinical trials in developing nations.The market includes organizations that offer services such as the development of cell lines, upstream and downstream processes, analytical methods, and formulations. These organizations specialize in developing and manufacturing stable cell lines that are extensively used in several important applications, including drug screening, gene functional studies, and biologic production.

Growing M&A and collaboration activities between biopharma companies and CDOs are yet another factor assisting in market growth allowing more financial stability and amalgamation of advanced & specialized technologies. For instance, in September 2022, Lonza., collaborated with biotechnology company Touchlight to expand its product portfolio with different sources of DNA for developing mRNA. Touchlight partnered to gain access to Lonza's novel doggybone DNA (dbDNA) technology.

Many biopharma and Pharma companies are increasingly looking to outsource their activities as it helps accelerate the workflow (speed) of the company, provide unique specialized services, decrease drug development costs, and provide expertise. These factors are expected to boost the biologics contract development industry's growth.

During the COVID-19 pandemic, most clinical trials were focused on developing new therapies for treating COVID-19. However, in the post-pandemic period, research is expected to focus on cancer owing to rising incidences. Biologics such as monoclonal antibodies have gained significant popularity in treating cancer. The high potential of biologics in treating cancer and the growing number of cancer studies are likely to support the growth of the market in the coming years.

Biologics Contract Development Market Report Highlights

  • Mammalian source emerged as the largest product segment in 2022 with over 52.0% share, as the majority of research is being carried out using mammalian cell lines
  • Process development is expected to witness the highest CAGR over the forecast period, as many companies are opting to outsource the production of recombinant proteins and monoclonal antibodies (MABs)
  • North America dominated the global market in 2019. An increase in strategic acquisitions & partnerships and a rise in demand for specialized testing services are likely to have a positive impact
  • Asia Pacific is expected to register the highest CAGR over the forecast period, owing to various amendments made by regulatory organizations to change clinical trials evaluation standards in tandem with global requirements and rising investment in the Asia Pacific region

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Source Type
    • 1.1.2 Service Type
    • 1.1.3 Disease Indication Type
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Region-Wise Market Calculation
    • 1.6.1 Region-Wise Market: Base Estimates
    • 1.6.2 Global Market: Cagr Calculation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis (Model 1)
    • 1.7.2 Volume Price Analysis (Model 2)
      • 1.7.2.1 Service Segment Analysis
  • 1.8 List Of Primary Sources
  • 1.9 List Of Abbreviations
  • 1.10 List Of Secondary Sources
  • 1.11 Objectives
    • 1.11.1 Objective - 1:
    • 1.11.2 Objective - 2:
    • 1.11.3 Objective - 3:
    • 1.11.4 Objective - 4:

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Biologics Contract Development Market: Variables, Trends, & Scope

  • 3.1 Market Segmentation And Scope
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Increasing Adoption Of Advanced Technologies
    • 3.2.3 Increasing Mergers And Collaborations
    • 3.2.4 Favorable Environment For Clinical Trials In Developing Countries
    • 3.2.5 Increasing Outsourcing Of R&D Activities
    • 3.2.6 Market Restraint Analysis
    • 3.2.7 Intellectual Property Rights Issues
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Biologics Contract Development: Market Analysis Tools
    • 3.4.1 Industry Analysis - Porter's Five Forces
    • 3.4.2 Pestel Analysis
  • 3.5 COVID-19 Impact On The Biologics Contract Development Market

Chapter 4 Biologics Contract Development Market: Source Type Segment Analysis

  • 4.1 Biologics Contract Development Market: Market Share Analysis, 2022 & 2030
    • 4.1.1 Microbial
      • 4.1.1.1 Microbial Market, 2018 - 2030 (USD Million)
      • 4.1.1.2 Mammalian
      • 4.1.1.2.1 Mammalian Market, 2018 - 2030 (USD Million)
      • 4.1.1.3 Others
      • 4.1.1.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Biologics Contract Development Market: Service Segment Analysis

  • 5.1 Biologics Contract Development Market: Market Share Analysis, 2022 & 2030
  • 5.2 Cell Line Development
    • 5.2.1 Cell Line Development Market, 2018 - 2030 (USD Million)
      • 5.2.1.1 Microbial Cell Line Development
      • 5.2.1.1.1 Microbial Cell Line Development Market, 2018 - 2030 (USD Million)
      • 5.2.1.2 Mammalian Cell Line Development
      • 5.2.1.2.1 Mammalian Cell Line Development Market, 2018 - 2030 (USD Million)
      • 5.2.1.3 Others
      • 5.2.1.3.1 Others Market, 2018 - 2030 (USD Million)
    • 5.2.2 Process Development
      • 5.2.2.1 Process Development market, 2018 - 2030 (USD Million)
      • 5.2.2.2 Upstream Process Development
      • 5.2.2.1.1 Upstream Process Development Market, 2018 - 2030 (USD Million)
      • 5.2.2.1.1.1 Microbial
      • 5.2.2.1.1.1.1 Microbial Market, 2018 - 2030 (USD Million)
      • 5.2.2.1.2.1 Mammalian
      • 5.2.2.1.2.1.1 Mammalian Market, 2018 - 2030 (USD Million)
      • 5.2.2.1.3.1 Others
      • 5.2.2.1.3.1.1 Others Market, 2018 - 2030 (USD Million)
    • 5.2.3 Downstream Process Development
      • 5.2.3.1 Downstream Process Development, 2018 - 2030 (USD Million)
      • 5.2.3.1.1 Impurity, Isolation, & Identification
      • 5.2.3.1.1.1 Impurity, Isolation, & Identification Market, 2018 - 2030 (USD Million)
      • 5.2.3.1.2 Physicochemical Characterization
      • 5.2.3.1.2.1 Physicochemical Characterization Market, 2018 - 2030 (USD Million)
      • 5.2.3.1.3 Pharmaceutical Analysis
      • 5.2.3.1.3.1 Pharmaceutical Analysis Market, 2018 - 2030 (USD Million)
      • 5.2.3.1.4 Others
      • 5.2.3.1.4.1 Others Market, 2018 - 2030 (USD Million)
    • 5.3.4 Downstream Process, By Product
      • 5.3.4.1 Mabs (Monoclonal Antibodies)
      • 5.3.4.1.1 Mabs (Monoclonal Antibodies) Market, 2018 - 2030 (USD Million)
      • 5.3.4.2. Recombinant Proteins
      • 5.3.4.2.1 Recombinant Proteins Analysis Market, 2018 - 2030 (USD Million)
      • 5.3.4.3 Others
      • 5.3.4.3.1 Others Market, 2018 - 2030 (USD Million)
  • 5.3 Other Services (Quality And Regulatory Services, Etc)
    • 5.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Biologics Contract Development Market: Indication Segment Analysis

  • 6.1 Biologics Contract Development Market: Market Share Analysis, 2022 & 2030
  • 6.2 Oncology
    • 6.2.1 Oncology Market, 2018 - 2030 (USD Million)
  • 6.3 Immunological Disorders
    • 6.3.1 Immunological Disorders Market, 2018 - 2030 (USD Million)
  • 6.4 Cardiovascular Disorders
    • 6.4.1 Cardiovascular Disorders Market, 2018 - 2030 (USD Million)
  • 6.5 Hematological Disorders
    • 6.5.1 Hematological Disorders Market, 2018 - 2030 (USD Million)
  • 6.6 Others
    • 6.6.1 others Market, 2018 - 2030 (USD Million)

Chapter 7 Biologics Contract Development Market: Regional Analysis

  • 7.1 Biologics Contract Development: Regional Market Share Analysis, 2022 & 2030
  • 7.2 North America
    • 7.2.1 North America Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada Biologics Contract Development Market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 UK Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain Biologics Contract Development Market, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.4.2 China
      • 7.4.2.1 China Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.4.3 India
      • 7.4.3.1 India Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.4.4 Japan
      • 7.4.4.1 Japan Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Australia Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea Biologics Contract Development Market, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.5.5 Colombia
      • 7.5.5.1 Colombia Biologics Contract Development Market, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia Biologics Contract Development Market, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE Biologics Contract Development Market, 2018 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive Landscape
  • 8.2 Company Profile
    • 8.2.1 Wuxi Biologics
      • 8.2.1.1 Company Overview
      • 8.2.1.2 Financial Performance
      • 8.2.1.3 Service Benchmarking
      • 8.2.1.4 Strategic Initiatives
    • 8.2.2 Abzena Ltd
      • 8.2.2.1 Company Overview
      • 8.2.2.2 Service Benchmarking
      • 8.2.2.3 Strategic Initiatives:
    • 8.2.3 Fujifilm Diosynth Biotechnologies
      • 8.2.3.1 Company Overview
      • 8.2.3.2 Financial Performance
      • 8.2.3.3 Service Benchmarking
      • 8.2.3.4 Strategic Initiatives
    • 8.2.4 Kbi Biopharma
      • 8.2.4.1 Company Overview
      • 8.2.4.2 Service Benchmarking
      • 8.2.4.3 Strategic Initiatives
    • 8.2.5 Agc Biologics
      • 8.2.5.1 Company Overview
      • 8.2.5.2 Financial Performance
      • 8.2.5.3 Service Benchmarking
      • 8.2.5.4 Strategic Initiatives:
    • 8.2.6 Thermo Fischer Scientific Inc.
      • 8.2.6.1 Company Overview
      • 8.2.6.2 Financial Performance
      • 8.2.6.3 Service Benchmarking
      • 8.2.6.4 Strategic Initiatives:
    • 8.2.7 Curia Global, Inc
      • 8.2.7.1 Company Overview
      • 8.2.7.2 Service Benchmarking
      • 8.2.7.3 Strategic Initiatives:
    • 8.2.8 Genscript
      • 8.2.8.1 Company Overview
      • 8.2.8.2 Financial Performance
      • 8.2.8.3 Service Benchmarking
      • 8.2.8.4 Strategic Initiatives
    • 8.2.9 Bionova Scientific Inc.
      • 8.2.9.1 Company Overview
      • 8.2.9.2 Service Benchmarking
    • 8.2.10 Bioxcellence (Boehringer Ingelheim Biopharmaceuticals Gmbh)
      • 8.2.10.1 Company Overview
      • 8.2.10.2 Financial Performance
      • 8.2.10.3 Service Benchmarking
      • 8.2.10.4 Strategic Initiatives:
    • 8.2.11 Stc Biologics
      • 8.2.11.1 Company Overview
      • 8.2.11.2 Service Benchmarking

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Biologics Contract Development Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 5 Global Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 6 Global Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 7 North America Biologics Contract Development Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 9 North America Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 10 North America Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 11 U.S. Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 12 U.S. Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 13 U.S. Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 14 Canada Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 15 Canada Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 16 Canada Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 17 Europe Biologics Contract Development Market, By Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 19 Europe Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 20 Europe Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 21 Germany Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 22 Germany Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 23 Germany Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 24 UK Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 25 UK Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 26 UK Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 27 France Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 28 France Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 29 France Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 30 Italy Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 31 Italy Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 32 Italy Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 33 Spain Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 34 Spain Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 35 Spain Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 36 Denmark Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 37 Denmark Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 38 Denmark Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 39 Sweden Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 40 Sweden Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 41 Sweden Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 42 Norway Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 43 Norway Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 44 Norway Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Biologics Contract Development Market, By Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 49 China Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 50 China Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 51 China Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 52 Japan Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 53 Japan Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 54 Japan Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 55 India Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 56 India Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 57 India Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 58 Australia Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 59 Australia Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 60 Australia Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 61 South Korea Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 62 South Korea Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 63 South Korea Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 64 Thailand Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 65 Thailand Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 66 Thailand Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 67 Latin America Biologics Contract Development Market, By Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 69 Latin America Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 70 Latin America Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 71 Brazil Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 72 Brazil Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 73 Brazil Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 74 Mexico Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 75 Mexico Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 76 Mexico Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 77 Argentina Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 78 Argentina Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 79 Argentina Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 80 Colombia Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 81 Colombia Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 82 Colombia Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 83 Middle East and Africa Biologics Contract Development Market, By Country, 2018 - 2030 (USD Million)
  • Table 84 Middle East and Africa Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 85 Middle East and Africa Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 86 Middle East and Africa Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 87 South Africa Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 88 South Africa Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 89 South Africa Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 93 UAE Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 94 UAE Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 95 UAE Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Biologics Contract Development Market, by Source, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Biologics Contract Development Market, by Service, 2018 - 2030 (USD Million)
  • Table 98 Kuwait Biologics Contract Development Market, by Indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity flow analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 Biologics Contract Development market snapshot (2022)
  • Fig. 11 Biologics Contract Development market segmentation
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 17 Biologics Contract Development market product type outlook: Segment dashboard
  • Fig. 18 Biologics Contract Development market: product movement analysis
  • Fig. 19 Microbial market, 2018 - 2030 (USD Million)
  • Fig. 20 Mammalian market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Biologics Contract Development market service outlook: Segment dashboard
  • Fig. 23 Biologics Contract Development market: product movement analysis
  • Fig. 24 Cell Line Development market, 2018 - 2030 (USD Million)
  • Fig. 25 Microbial Cell Line Development market, 2018 - 2030 (USD Million)
  • Fig. 26 Mammalian Cell Line Development market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Process development market, 2018 - 2030 (USD Million)
  • Fig. 29 Upstream Process Development market, 2018 - 2030 (USD Million)
  • Fig. 30 Microbial market, 2018 - 2030 (USD Million)
  • Fig. 31 Mammalian market, 2018 - 2030 (USD Million)
  • Fig. 32 Others market, 2018 - 2030 (USD Million)
  • Fig. 33 Downstream Process Development market, 2018 - 2030 (USD Million)
  • Fig. 34 Impurity, isolation, & identification market, 2018 - 2030 (USD Million)
  • Fig. 35 Physicochemical characterization market, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical analysis market, 2018 - 2030 (USD Million)
  • Fig. 37 Others market, 2018 - 2030 (USD Million)
  • Fig. 38 MABS (Monoclonal Antibodies) market, 2018 - 2030 (USD Million)
  • Fig. 39 Recombinant proteins market, 2018 - 2030 (USD Million)
  • Fig. 40 Others market, 2018 - 2030 (USD Million)
  • Fig. 41 Others market, 2018 - 2030 (USD Million)
  • Fig. 42 Biologics Contract Development market indication outlook: Segment dashboard
  • Fig. 43 Biologics Contract Development market: indication movement analysis
  • Fig. 44 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 45 Immunological disorders market, 2018 - 2030 (USD Million)
  • Fig. 46 Cardiovascular disorders market, 2018 - 2030 (USD Million)
  • Fig. 47 Hematological disorders market, 2018 - 2030 (USD Million)
  • Fig. 48 Others market, 2018 - 2030 (USD Million)
  • Fig. 49 Regional market: Key takeaways
  • Fig. 50 Regional outlook, 2022 & 2030
  • Fig. 51 North America market, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 53 Canada market, 2018 - 2030 (USD Million)
  • Fig. 54 Europe market, 2018 - 2030 (USD Million)
  • Fig. 55 UK market, 2018 - 2030 (USD Million)
  • Fig. 56 Germany market, 2018 - 2030 (USD Million)
  • Fig. 57 France market, 2018 - 2030 (USD Million)
  • Fig. 58 Italy market, 2018 - 2030 (USD Million)
  • Fig. 59 Spain market, 2018 - 2030 (USD Million)
  • Fig. 60 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 61 China market, 2018 - 2030 (USD Million)
  • Fig. 62 India market, 2018 - 2030 (USD Million)
  • Fig. 63 Japan market, 2018 - 2030 (USD Million)
  • Fig. 64 Australia market, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 70 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 74 UAE market, 2018 - 2030 (USD Million)